Register for our free email digests:
Latest From Ferrer Therapeutics Inc.
2016 witnessed a second straight year of decline in the number of new active substance launches worldwide, but trend data show that this hard measure of R&D productivity was still healthy compared with industry's performance during the first decade of the century.
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Colgate-Palmolive Co.
- Senior Management
Ian Cook, Chmn., Pres. & CEO
Dennis Hickey, CFO
Lois Juliber, EVP, Chief, Operations, Developed Mkts.
John Reid, CTO
William S Shanahan, Pres. & COO
- Contact Info
Phone: (212) 310-2000
300 Park Ave.
New York, NY 10022-7499
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.